Literature DB >> 8064380

Role of cholecystokinin in the regulation of gastrointestinal motility.

J R Grider1.   

Abstract

Cholecystokinin, a hormone released from endocrine cells of the upper small intestine in response to amino acids and fatty acids in chyme, has potent effects on gut smooth muscle contractility. Depending on the region of the gut, the effect of cholecystokinin may be neurally mediated, direct, or both. Neurally-mediated effects may be relaxant or contractile depending on the transmitter released by cholecystokinin. Based on mimicry by infusion of cholecystokinin to postprandial levels and the ability of specific cholecystokinin receptor antagonists to abolish effects of endogenous cholecystokinin released in response to a meal, three physiological effects of cholecystokinin, all of which are neurally-mediated, have been identified: contraction of the gallbladder mediated by cholecystokinin-induced release of acetylcholine, relaxation of the sphincter of Oddi mediated by cholecystokinin-induced release of vasoactive intestinal peptide and inhibition of gastric emptying mediated by cholecystokinin-induced activation of an inhibitory vago-vagal reflex involving vasoactive intestinal peptide-induced relaxation of the gastric fundus. Gallbladder contraction and relaxation of the sphincter of Oddi regulate the flow of bile, and inhibition of gastric emptying regulates the flow of chyme into the duodenum. Combined with the potent stimulation of pancreatic enzyme secretion by cholecystokinin, these effects insure optimal conditions for digestion and absorption of nutrients by the intestine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064380     DOI: 10.1093/jn/124.suppl_8.1334S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  23 in total

1.  [Hormonal and metabolic functions of the small intestine].

Authors:  H Wittenburg; U Tennert; J Mössner
Journal:  Internist (Berl)       Date:  2010-06       Impact factor: 0.743

Review 2.  Central control of body weight and appetite.

Authors:  Stephen C Woods; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

3.  Differential display of intestinal mRNAs regulated by dietary zinc.

Authors:  R K Blanchard; R J Cousins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 4.  Gut Microbiota in Obesity and Undernutrition.

Authors:  Nicolien C de Clercq; Albert K Groen; Johannes A Romijn; Max Nieuwdorp
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

5.  Esophageal dysmotility is more common than gastroparesis in diabetes mellitus and is associated with retinopathy.

Authors:  Rita J Gustafsson; Bengt Littorin; Kerstin Berntorp; Anders Frid; Ola Thorsson; Rolf Olsson; Olle Ekberg; Bodil Ohlsson
Journal:  Rev Diabet Stud       Date:  2011-08-10

6.  177Lu-DOTA-coupled minigastrin peptides: promising theranostic agents in neuroendocrine cancers.

Authors:  Syed Faheem Askari Rizvi; Syed Ali Raza Naqvi; Samina Roohi; Tauqir A Sherazi; Rashid Rasheed
Journal:  Mol Biol Rep       Date:  2018-08-24       Impact factor: 2.316

7.  Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis.

Authors:  David Q-H Wang; Frank Schmitz; Alan S Kopin; Martin C Carey
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 8.  White vegetables: glycemia and satiety.

Authors:  G Harvey Anderson; Chesarahmia Dojo Soeandy; Christopher E Smith
Journal:  Adv Nutr       Date:  2013-05-01       Impact factor: 8.701

9.  Diminished gallbladder motility in Rotund leptin-resistant obese mice.

Authors:  Shannon J Graewin; Khoi Q Tran; Jurgen K Naggert; Keun-Ho Lee; Debbie Swartz-Basile; Attila Nakeeb; Henry A Pitt
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

10.  Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the dog.

Authors:  C Webber; C A Stokes; S Persiani; F Makovec; A McBurney; R P Kapil; B A John; M D'Amato; L F Chasseaud
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jan-Mar       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.